The effects of cholinergic drugs on rat neocortical high-voltage spindles in ketanserin-treated rats

European Journal of Pharmacology

Volumn 316, Issue 2-3, 1996, Pages 181-193

  Jäkälä, Pekka ^a,b   Björklund, Markus ^a   Koivisto, Esa ^a   Riekkinen Jr , Paavo ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

5 HT2 receptor; Anticholinesterase; Muscarinic acetylcholine receptor; Neocortical high voltage spindle; Rat; Thalamocortical oscillation

Indexed keywords

CHOLINESTERASE INHIBITOR; KETANSERIN; MUSCARINIC AGENT; OXOTREMORINE; PHYSOSTIGMINE; PILOCARPINE; SEROTONIN 2A RECEPTOR; TACRINE;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ELECTROPHYSIOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; KETANSERIN; MALE; OXOTREMORINE; PHYSOSTIGMINE; PILOCARPINE; RATS; RATS, WISTAR;

EID: 0030571524     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00679-6     Document Type: Article

References (59)

1. Aghajanian, G.K. and C.P. Vandermaelen, 1986, Specific systems of the reticular core: Serotonin, in: Handbook of Physiology. The Nervous System. Intrinsic Regulatory Systems of the Brain (American Physiological Society, Bethesda, MD), Vol. IV, p. 237.
2. Allen, S.S., J.S. Benton, M.J. Goodhardt, E.A. Hann, N.R. Sims, C.C.T. Smith, J.A. Spillane, D.M. Bowen and A.N. Davison, 1983, Biochemical evidence of selective nerve cell changes in the normal ageing human and rat brain, J. Neurochem. 41, 256.
3. Baskys, A., C.E. Niesen and P.C. Carlen, P.C., 1987, Altered modulatory actions of serotonin on dentate granule cells of aged rats, Brain Res. 419, 112.
4. Beani, L., C. Bianchi, L. Ferraro, L. Nilsson, A. Nordberg, L. Romanelli, P. Spalluto, A. Sundwall and E. Tanganelli, 1989, Effects of nicotine on the release of acetylcholine and amino acids in the brain, in: Nicotine receptors in the CNS: Their role in synaptic transmission, eds. A. Nordberg, K. Fuxe, B. Holmstedt and A. Sundwall (Elsevier Science Publishers, Amsterdam) p. 149.
5. Boess, F.G. and I.L. Martin, 1994, Molecular biology of 5-HT receptors, Neuropharmacology 33, 275.
6. Bräuner-Osborne, H. and M.R. Brann, 1996, Pharmacology of muscarinic acetylcholine receptor subtypes (m1-m5): High throughput assays in mammalian cells, Eur. J. Pharmacol. 295, 93.
7. Buzsáki, G., R.G. Bickford, G. Ponomaref, L.J. Thal, R. Mandel and F.H. Gage, 1988, Nucleus basalis and thalamic control of neocortical activity in the freely moving rat, J. Neurosci. 8, 4007.
8. Buzsáki, G., I. Laszlovsky, A. Lajtha and C. Vadasz, 1990, Spike-and-wave neocortical patterns in rats: Genetic and aminergic control, Neuroscience 38, 323.
9. Danober, L., A. Depaulis, C. Marescaux and M. Vergnes, 1993, Effects of cholinergic drugs on genetic absence seizures in rats, Eur. J. Pharmacol. 234, 263.
10. Flynn, D.D. and D.C. Mash, 1989. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by THA, J. Pharmacol. Exp. Ther. 250, 573.
11. 3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain, Synapse 14, 283.
12. 3H]acetylcholine release from slices of rat hippocampus, striatum and cortex, Brain Res. 123, 311.
13. Jacobs, B.L. and E.C. Azmitia, 1992, Structure and function of the brain serotonin system, Physiol. Rev. 72, 165.
14. 2 receptor stimulation, Eur. J. Pharmacol. 299, 47.
15. 2 receptor subtype specific drugs, Eur. J. Pharmacol. 282, 39.
16. Levey, A., A.E. Hallanger and B.H. Wainer, 1987, Cholinergic nucleus basalis may influence the cortex via the thalamus, Neurosci. Lett. 74, 7.
17. 2 receptor binding sites. Binding properties, brain distribution, and functional role, Mol. Pharmacol. 21, 301.
18. Mann, D.M.A. and P.D. Yates, 1983, Serotonergic nerve cells in Alzheimer's disease, J. Neurol. Neurosurg. Psychiatry 46, 96.
19. Martin, G.R. and P.P.A. Humphrey, 1994, Receptors for 5-hydroxytryptamine: Current perspectives on classification and nomenclature, Neuropharmacology 33, 261.
20. McCormick, D.A., 1989, Cholinergic and noradrenergic modulation of thalamocortical processing, Trends Neurosci. 12, 215.
21. McCormick, D.A., 1990, Cellular mechanisms of cholinergic control of neocortical and thalamic neuronal excitability, in: Brain Cholinergic Systems, eds. M. Steriade and D. Biesold (Oxford University Press, Oxford) p. 236.
22. McCormick, D.A., 1992, Neurotransmitter actions in the thalamus and cerebral cortex, J. Clin. Neurophysiol. 9, 212.
23. McCormick, D.A. and Z. Wang, 1991, Serotonin and noradrenaline excite GABAergic neurons of the guinea-pig and cat nucleus reticularis thalami, J. Physiol. 442, 235.
24. Micheletti, G., J.-M. Warter, C. Marescaux, A. Depaulis, I. Tranchant, L. Rumbach and M. Vergnes, 1987, Effects of drugs affecting noradrenergic transmission in rats with spontaneous petit mal seizures, Eur. J. Pharmacol. 135, 397.
25. Molineaux, S., T. Jessell, R. Axel and D. Julius, 1989, 5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system, Proc. Natl. Acad. Sci. 86, 6793.
26. Noronha-Blob, L., V. Lowe, A, Patton, B. Canning, D. Costello and W.J. Kinnier, 1989, Muscarinic receptors: Relationship among phosphoinositide breakdown, adenylate cyclase inhibition, in vitro detrusor muscle contractions and in vivo cystometrogram studies in guinea pig bladder, J. Pharmacol. Exp. Ther. 249, 843.
27. Pape, H.-C. and D.A. McCormick, 1989, Noradrenaline and serotonin selectively modulate thalamic burst firing by enhancing a hyperpolarization-activated cation current, Nature 340, 715.
28. Pearce, B.D. and L.T. Potter, 1988, Effects of THA on M1 and M2 muscarine receptors, Neurosci. Lett. 88, 281.
29. Perry, E.K., C.J. Smith, J.A. Court, J.R. Bonham, M. Rodway and J.R. Atack, 1988, Interaction of 9-amino-1,2,3,4-THA (THA) with human cortical nicotinic amd muscarinic receptor binding in vitro, Neurosci. Lett. 91, 211.
30. Potter, L.T. and C.A. Ferrendelli, 1989, Affinities of different cholinergic agonists for the high and low affinity states of hippocampal M1 muscarine receptors, J. Pharmacol. Exp. Ther. 248, 974.
31. Radek, R.J., 1993, Effects of nicotine on cortical high voltage spindles in rats, Brain Res. 625, 23.
32. Reinikainen, K.J., H. Soininen and P.J. Riekkinen, 1990, Neurotransmitter changes in Alzheimer's disease: Implications to diagnostics and therapy, J. Neurosci. Res. 27, 576.
33. Riekkinen Jr., J. Kuitunen and M. Riekkinen, 1995, Effects of thalamic and nucleus basalis infusions of nicotine on cortical EEG, NeuroReport 6, 1625.
34. Riekkinen Jr., P., M. Riekkinen and J. Sirviö, 1993a, Effects of nicotine on neocortical electrical activity in rats, J. Pharmacol. Exp. Ther. 267, 776.
35. Riekkinen Jr., P., J. Sirviö, R. Miettinen and P. Riekkinen, 1990, Interaction between raphe dorsalis and nucleus basalis magnocellularis in the regulation of high-voltage spindle activity in rat neocortex, Brain Res. 526, 31.
36. Riekkinen Jr., P., M. Riekkinen, A. Fisher, T. Ekonsalo and J. Sirviö, 1993b, Effects of muscarinic receptor agonists and anticholinesterase drugs on high-voltage spindles and slow waves, Eur. J. Pharmacol. 240, 1.
37. Riekkinen Jr., P., M. Riekkinen, J. Sirviö, R. Miettinen and P. Riekkinen, 1992, Loss of cholinergic neurons in the nucleus basalis induces neocortical electroencephalographic and passive avoidance deficits, Neuroscience 47, 823.
38. Riekkinen Jr., P., J. Sirviö, A. Valjakka, M. Riekkinen, R. Lammintausta and P. Riekkinen, 1991, Effects of atipamezole and tetrahydroaminoacridine on nucleus basalis lesion-induced EEG changes, Brain Res. Bull. 27, 231.
39. Ryan, L.J., 1985, Cholinergic regulation of neocortical spindling in DBA/2 mice, Exp. Neurol. 89, 372.
40. Scauf, C.L. and A. Sattin, 1988, Tetrahydroaminoacridine blocks potassium channels and inhibits sodium interaction in Myxicola, J. Pharmacol. Exp. Ther. 243, 609.
41. Sethy, V.H. and J.W. Francis, 1988, Regulation of brain acetylcholine concentration by muscarinic receptors, J. Pharmacol. Exp. Ther. 243, 609.
42. Sirviö, J., P. Riekkinen Jr., P. Jäkälä and P. Riekkinen, 1994, Experimental studies on the role of serotonin in cognition, Prog. Neurobiol. 43, 363.
43. Sirviö, J., A. Pitkänen, A. Pääkkönen, J. Partanen and P. Riekkinen, 1989, Brain cholinergic enzymes and cortical EEG activity in young and adult rats, Comp. Biochem. Physiol. 94C, 277.
44. Soininen, H., J. Partanen, V. Laulumaa, E.-L. Helkala, M. Laakso and P.J. Riekkinen, 1989, Longitudinal EEG spectral analysis in early stage of Alzheimer's disease, Electroencephalogr. Clin. Neurophysiol. 72, 290.
45. Soininen, H, K. Reinikainen, J. Partanen, E.-L. Helkala, L. Paljärvi and P.J. Riekkinen, 1992, Slowing of electroencephalogram and choline acetyltransferase activity in post-mortem frontal cortex in definite Alzheimer's disease, Neuroscience 49, 529.
46. Steinbusch, H.W.M., 1981, Distribution of serotonin-immunoreactivity in the central nervous system of the rat - cell bodies and terminals, Neuroscience 6, 557.
47. Steriade, M. and G. Buzsáki, 1990, Parallel activation of thalamic and cortical neurons by brainstem and forebrain cholinergic systems, in: Brain Cholinergic Systems, eds. M. Steriade and D. Biesold (Oxford University Press) p. 3.
48. Steriade, M. and R.R. Llinás, 1988, The functional stages of the thalamus and associated neuronal interplay, Physiol. Rev. 68, 649.
49. Steriade, M., D.A. McCormick and T.J. Sejnowski, 1993. Thalamocortical oscillations in the sleeping and aroused brain, Science 262, 679.
50. 3H]acetylcholine from rat hippocampal slices: Effects of septal lesion and of graded concentration of muscarinic agonists and antagonists, Brain Res. 128, 285.
51. Tachiki, K.H., K. Spidell, L. Samuels, R. Ritzmann, A. Steinberge, R.L. Lloyd, W.K. Summers and A. Kling, 1988, Tacrine: Levels and effects on biogenic amines and their metabolites in specific areas of the rat brain, in: Current Research in Alzheimer Therapy: Cholinesterase Inhibitors, eds. E. Giacobini and R. Becker, (Taylor and Francis, New York, NY).
52. Vanderwolf, C.H. and G.B. Baker, 1986, Evidence that serotonin mediates non-cholinergic neocortical low voltage fast activity, non-cholinergic hippocampal rhythmical slow activity and contributes to intelligent behavior, Brain Res. 374, 342.
53. Vanderwolf, C.H., L.W.S. Leung, G.B. Baker and D.J. Stewart, 1989, The role of serotonin in the control of cerebral activity: Studies with intracerebral 5,7-dihydroxytryptamine, Brain Res. 504, 181.
54. Wada, E., K. Wada, J. Baulter, E. Deneris, S. Heinemann, J. Patrick and L.W. Swanson, 1989, Distribution of alpha2, alpha3, alpha4 and beta2 neuronal nicotinic receptor subunit mRNA in the central nervous system: A hybridization histochemical study in the rat, J. Comp. Neurol. 284, 314.
55. Wainer, B.H. and M.-M. Mesulam, 1990, Ascending cholinergic pathways in the rat brain, in: Brain Cholinergic Systems, eds. M. Steriade and D. Biesold (Oxford University Press, Oxford) p. 65.
56. 3H]AF-DX116, Brain Res. 477, 322.
57. Wei, J., E.A. Walton, A. Milici and J.J. Buccafusco, 1994, M1-M5 muscarinic receptor distribution in rats CNS by RT-PCR and HPLC, J. Neurochem. 63, 815.
58. Yamato, T. and A. Hirano, 1985, Nucleus raphe dorsalis in Alzheimer's disease: Neurofibrillary tangles and loss of large neurons, Ann. Neurol. 17, 573.
59. Zaborsky, L., W.E. Cullinan and A. Braun, 1991, Afferents to basal forebrain cholinergic projection neurons: An update, in: Basal Forebrain: Anatomy to Function, eds. C.T. Apier, P.W. Kaliwas and I. Hanin (Plenum Press, New York, NY).